Compulsory Patent Licensing of Drugs in Canada: A Comment on the Debate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Compulsory Patent Licensing of Drugs in Canada: A Comment on the Debate

Published:1981 Issue:4 Volume:7 Page:559
ISSN:0317-0861
Container-title:Canadian Public Policy / Analyse de Politiques
language:
Short-container-title:Canadian Public Policy / Analyse de Politiques

Author:

Gorecki Paul K.,Henderson Ida

Publisher

JSTOR

Subject

Public Administration,Sociology and Political Science

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis;Globalization and Health;2019-06-27

2. Pharmaceutical policy reform in Canada: lessons from history;Health Economics, Policy and Law;2018-02-01

3. Access to medicines and domestic compulsory licensing: Learning from Canada and Thailand;Global Public Health;2010-03-15

4. Determinants of R & D Performed in Canada by U.S. Owned Pharmaceutical Multinationals*;Canadian Journal of Administrative Sciences / Revue Canadienne des Sciences de l'Administration;2009-04-08

5. Pharmaceutical Cost Control In Canada: Does It Work?;Health Affairs;2001-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP